Glutamic Acid Decarboxylase Autoantibody Syndrome Presenting as Schizophrenia
Authors:
- Souhel NajjarSNSouhel Najjar
- Daniel PearlmanDPDaniel Pearlman
- David ZagzagDZDavid Zagzag
- John GolfinosJGJohn Golfinos
- Orrin DevinskyODOrrin Devinsky
- 1 March 2012
- journal article
- case report
- Published by Wolters Kluwer Health in The Neurologist
- Vol. 18 (2) , 88-91
Abstract
Glutamic acid decarboxylase (GAD) is the rate-limiting enzyme converting glutamate into γ-aminobutyric acid. Impaired GAD function can alter motor, cognitive, and behavioral function. Anti-GAD antibodies (GADAbs) can cause several neurological disorders. However, the association between anti-GADAbs and pure psychosis, without seizures or focal neurological deficits, is not well defined. A 19-year-old woman with recent-onset psychotic disorder was diagnosed with schizophrenia. Brain magnetic resonance imaging and cerebrospinal fluid analysis were normal. Serum anti-GADAb titers were elevated. Brain biopsy showed subcortical gliosis and microglia-macrophage infiltration. The clinical syndrome improved with immune therapy. Severe psychosis and mild cognitive decline without other neurological features, meeting the Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision diagnostic criteria for schizophrenia, can result from brain inflammation associated with elevated serum anti-GADAbs.Keywords
This publication has 12 references indexed in Scilit:
- Central Nervous System Destruction Mediated by Glutamic Acid Decarboxylase-Specific CD4+ T CellsThe Journal of Immunology, 2010
- A case of immune-mediated encephalopathy showing refractory epilepsy and extensive brain MRI lesions associated with anti-glutamic acid decarboxylase antibodyRinsho Shinkeigaku, 2010
- Decreased glutamic acid decarboxylase67 mRNA expression in multiple brain areas of patients with schizophrenia and mood disordersJournal of Psychiatric Research, 2009
- Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this associationBrain, 2008
- Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodiesJournal of Neuroimmunology, 2008
- Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlatesBrain, 2005
- GABAergic dysfunction in schizophrenia: new treatment strategies on the horizonPsychopharmacology, 2005
- Encephalitis associated with glutamic acid decarboxylase autoantibodiesNeurology, 2001
- Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunityNeurology, 1997
- INCREASED BRAIN DOPAMINE AND REDUCED GLUTAMIC ACID DECARBOXYLASE AND CHOLINE ACETYL TRANSFERASE ACTIVITY IN SCHIZOPHRENIA AND RELATED PSYCHOSESThe Lancet, 1977